<!DOCTYPE html><html lang="en"><head><title>Help for package frequentistSSDBinary</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav class="package" aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {frequentistSSDBinary}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#get_oc_2arm_binary'>
<p>Generate operating characteristics for Two-Stage Screened Selection Design for Randomized Phase II Trials with Binary Endpoints</p></a></li>
<li><a href='#get_oc_3arm_binary'>
<p>Generate operating characteristics for Two-Stage Screened Selection Design for Randomized Phase II Trials with Binary Endpoints for 3 arms</p></a></li>
<li><a href='#optimal_2arm_binary'>
<p>Find optimal design parameters</p></a></li>
<li><a href='#optimal_3arm_binary'>
<p>Find optimal design parameters</p></a></li>
<li><a href='#sample_size_2arm_binary'>
<p>Calculate the sample size for each arm in a two-arm trial</p></a></li>
<li><a href='#sample_size_3arm_binary'>
<p>Calculate the sample size for each arm in a three-arm study</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table role='presentation'>
<tr>
<td>Type:</td>
<td>Package</td>
</tr>
<tr>
<td>Title:</td>
<td>Screened Selection Design with Binary Endpoints</td>
</tr>
<tr>
<td>Version:</td>
<td>0.1.0</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Chia-Wei Hsu &lt;Chia-Wei.Hsu@stjude.org&gt;</td>
</tr>
<tr>
<td>Description:</td>
<td>A study based on the screened selection design (SSD) is an exploratory phase II randomized trial with two or more arms but without concurrent control. The primary aim of the SSD trial is to pick a desirable treatment arm (e.g., in terms of the response rate) to recommend to the subsequent randomized phase IIb (with the concurrent control) or phase III. The proposed designs can “partially” control or provide the empirical type I error/false positive rate by an optimal algorithm (implemented by the optimal_2arm_binary() or optimal_3arm_binary() function) for each arm. All the design needed components (sample size, operating characteristics) are supported.</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-2">GPL-2</a></td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>Depends:</td>
<td>mvtnorm, clinfun, ph2mult</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2024-06-26 03:27:31 UTC; chsu1</td>
</tr>
<tr>
<td>Author:</td>
<td>Chia-Wei Hsu [aut, cre],
  Zongheng Cai [aut],
  Haitao Pan [aut]</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2024-06-26 13:00:06 UTC</td>
</tr>
</table>
<hr>
<h2 id='get_oc_2arm_binary'>
Generate operating characteristics for Two-Stage Screened Selection Design for Randomized Phase II Trials with Binary Endpoints
</h2><span id='topic+get_oc_2arm_binary'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of Two-Stage Screened Selection Design for Randomized Phase II Trials with Binary Endpoints. The arguments for this function are from outputs of the functions of <code>sample_size_2arm_binary()</code> and <code>optimal_2arm_binary()</code>
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_2arm_binary(r1, r2, n1, n, p0, p1, p2, diff = 0, nsim, seed = 2483)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="get_oc_2arm_binary_+3A_r1">r1</code></td>
<td>

<p>the maximum number of successes in stage 1 which will terminate trial
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_r2">r2</code></td>
<td>

<p>the maximum number of successes in stage 2 not to warrant further investigation
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_n1">n1</code></td>
<td>

<p>the number of subjects in stage 1
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_n">n</code></td>
<td>

<p>the total number of subjects (stage 1 + stage 2)
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_p0">p0</code></td>
<td>

<p>the response rate of historical data
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_p1">p1</code></td>
<td>

<p>the response rate of arm 1
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_p2">p2</code></td>
<td>

<p>the response rate of arm 2
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_diff">diff</code></td>
<td>

<p>the equivalence margin
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_nsim">nsim</code></td>
<td>

<p>the number of simulated trials
</p>
</td></tr>
<tr><td><code id="get_oc_2arm_binary_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 2483
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_2arm_binary()</code> returns: (1) n: total sample size for each arm (2) SSD.Arm.A: selection probability of Arm A (3) SSD.Arm.B: selection probability of Arm B (4) SSD.No.Arm: the probability of no arms selected (5) diff: the equivalence margin (6) Mean.N.Arm.A: the average number of patients allocated to Arm A (7) Mean.N.Arm.B: the average number of patients allocated to Arm B
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Zongheng Cai, Haitao Pan
</p>


<h3>References</h3>

<p>Cai, Z., Pan, H., Wu, J., Hsu, C.W. (2024). Uncontrolled Randomized Screening Selection Design for Pediatric Oncology Trials. Accepted in Book Chapter of &quot;Master Protocol Clinical Trial for Efficient Evidence Generation&quot;
</p>
<p>Wu, J., Pan, H., &amp; Hsu, C. W. (2022). Two-stage screened selection designs for randomized phase II trials
with time-to-event endpoints. Biometrical Journal, 64(7), 1207-1218
</p>
<p>Yap, C., Pettitt, A. &amp; Billingham, L. Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol 13, 87 (2013)
</p>


<h3>Examples</h3>

<pre><code class='language-R'>get_oc_2arm_binary(r1 = 2, r2 = 6, n1 = 11, n = 21, p0 = 0.2,
                   p1 = 0.415, p2 = 0.615, nsim = 100)
</code></pre>

<hr>
<h2 id='get_oc_3arm_binary'>
Generate operating characteristics for Two-Stage Screened Selection Design for Randomized Phase II Trials with Binary Endpoints for 3 arms
</h2><span id='topic+get_oc_3arm_binary'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of Two-Stage Screened Selection Design for Randomized Phase II Trials with Binary Endpoints for 3 arms. The arguments for this function are from outputs of the functions of <code>sample_size_3arm_binary()</code> and <code>optimal_3arm_binary()</code>
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_3arm_binary(r1, r2, n1, n, p0, p1, p2, p3, diff = 0, nsim, seed = 2483)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="get_oc_3arm_binary_+3A_r1">r1</code></td>
<td>

<p>the maximum number of successes in stage 1 which will terminate trial
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_r2">r2</code></td>
<td>

<p>the maximum number of successes in stage 2 not to warrant further investigation
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_n1">n1</code></td>
<td>

<p>the number of subjects in stage 1
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_n">n</code></td>
<td>

<p>the total number of subjects (stage 1 + stage 2)
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_p0">p0</code></td>
<td>

<p>the response rate of historical data
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_p1">p1</code></td>
<td>

<p>the response rate of arm 1
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_p2">p2</code></td>
<td>

<p>the response rate of arm 2
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_p3">p3</code></td>
<td>

<p>the response rate of arm 3
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_diff">diff</code></td>
<td>

<p>the equivalence margin. The default value is diff = 0
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_nsim">nsim</code></td>
<td>

<p>the number of simulated trials
</p>
</td></tr>
<tr><td><code id="get_oc_3arm_binary_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 2483
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_3arm_binary()</code> returns: (1) n: total sample size for each arm (2) SSD.Arm.A: selection probability of Arm A (3) SSD.Arm.B: selection probability of Arm B (4) SSD.Arm.C: selection probability of Arm C (5) SSD.No.Arm: the probability of no arms selected (6) diff: the equivalence margin (7) Mean.N.Arm.A: the average number of patients allocated to Arm A (8) Mean.N.Arm.B: the average number of patients allocated to Arm B (9) Mean.N.Arm.C: the average number of patients allocated to Arm C
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Zongheng Cai, Haitao Pan
</p>


<h3>References</h3>

<p>Cai, Z., Pan, H., Wu, J., Hsu, C.W. (2024). Uncontrolled Randomized Screening Selection Design for Pediatric Oncology Trials. Accepted in Book Chapter of &quot;Master Protocol Clinical Trial for Efficient Evidence Generation&quot;
</p>
<p>Wu, J., Pan, H., &amp; Hsu, C. W. (2022). Two-stage screened selection designs for randomized phase II trials
with time-to-event endpoints. Biometrical Journal, 64(7), 1207-1218
</p>
<p>Yap, C., Pettitt, A. &amp; Billingham, L. Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol 13, 87 (2013)
</p>


<h3>Examples</h3>

<pre><code class='language-R'>get_oc_3arm_binary(r1 = 4, r2 = 25, n1 = 15, n = 82,
                   p0 = 0.2, p1 = 0.415, p2 = 0.515,
                   p3 = 0.615, nsim = 100)
</code></pre>

<hr>
<h2 id='optimal_2arm_binary'>
Find optimal design parameters
</h2><span id='topic+optimal_2arm_binary'></span>

<h3>Description</h3>

<p>Find the optimal parameters used in the <code>get_oc_2arm()</code> function
</p>


<h3>Usage</h3>

<pre><code class='language-R'>optimal_2arm_binary(p0, p1, p2, alpha = 0.1, beta = 0.2, tot_sample)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="optimal_2arm_binary_+3A_p0">p0</code></td>
<td>

<p>the response rate of historical data
</p>
</td></tr>
<tr><td><code id="optimal_2arm_binary_+3A_p1">p1</code></td>
<td>

<p>the response rate of arm 1
</p>
</td></tr>
<tr><td><code id="optimal_2arm_binary_+3A_p2">p2</code></td>
<td>

<p>the response rate of arm 2
</p>
</td></tr>
<tr><td><code id="optimal_2arm_binary_+3A_alpha">alpha</code></td>
<td>

<p>the type I error to be controlled. The default value is alpha = 0.1
</p>
</td></tr>
<tr><td><code id="optimal_2arm_binary_+3A_beta">beta</code></td>
<td>

<p>the type II error to be controlled. The default value is beta = 0.2
</p>
</td></tr>
<tr><td><code id="optimal_2arm_binary_+3A_tot_sample">tot_sample</code></td>
<td>

<p>the required sample size for each arm from function <code>sample_size_2arm_binary()</code>
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>optimal_2arm_binary()</code> returns: (1) alpha: type I error (2) beta: typeII error (3) r1: the maximum number of successes in stage 1 which will terminate trial (4) n1: the number of subjects in stage 1 (5) r2: the maximum number of successes in stage 2 not to warrant further investigation (6) n: the total number of subjects (stage 1 + stage 2) (7) ESS: the expected sample size for each arm (8) PS:the probability of early stopping
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Zongheng Cai, Haitao Pan
</p>


<h3>References</h3>

<p>Cai, Z., Pan, H., Wu, J., Hsu, C.W. (2024). Uncontrolled Randomized Screening Selection Design for Pediatric Oncology Trials. Accepted in Book Chapter of &quot;Master Protocol Clinical Trial for Efficient Evidence Generation&quot;
</p>
<p>Wu, J., Pan, H., &amp; Hsu, C. W. (2022). Two-stage screened selection designs for randomized phase II trials
with time-to-event endpoints. Biometrical Journal, 64(7), 1207-1218
</p>
<p>Yap, C., Pettitt, A. &amp; Billingham, L. Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol 13, 87 (2013)
</p>


<h3>Examples</h3>

<pre><code class='language-R'>optimal_2arm_binary(p0 = 0.2, p1 = 0.415, p2 = 0.615, tot_sample = 21)
</code></pre>

<hr>
<h2 id='optimal_3arm_binary'>
Find optimal design parameters
</h2><span id='topic+optimal_3arm_binary'></span>

<h3>Description</h3>

<p>Find the optimal parameters used in the <code>get_oc_3arm_binary()</code> function
</p>


<h3>Usage</h3>

<pre><code class='language-R'>optimal_3arm_binary(p0, p1, p2, p3, alpha = 0.1, beta = 0.2, tot_sample)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="optimal_3arm_binary_+3A_p0">p0</code></td>
<td>

<p>the response rate of historical data
</p>
</td></tr>
<tr><td><code id="optimal_3arm_binary_+3A_p1">p1</code></td>
<td>

<p>the response rate of arm 1
</p>
</td></tr>
<tr><td><code id="optimal_3arm_binary_+3A_p2">p2</code></td>
<td>

<p>the response rate of arm 2
</p>
</td></tr>
<tr><td><code id="optimal_3arm_binary_+3A_p3">p3</code></td>
<td>

<p>the response rate of arm 3
</p>
</td></tr>
<tr><td><code id="optimal_3arm_binary_+3A_alpha">alpha</code></td>
<td>

<p>the type I error to be controlled. The default value is alpha = 0.1
</p>
</td></tr>
<tr><td><code id="optimal_3arm_binary_+3A_beta">beta</code></td>
<td>

<p>the type II error to be controlled. The default value is beta = 0.2
</p>
</td></tr>
<tr><td><code id="optimal_3arm_binary_+3A_tot_sample">tot_sample</code></td>
<td>

<p>the required sample size for each arm from function <code>sample_size_3arm_binary()</code>
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>optimal_3arm_binary()</code> returns: (1) alpha: type I error (2) beta: typeII error (3) r1: the maximum number of successes in stage 1 which will terminate trial (4) n1: the number of subjects in stage 1 (5) r2: the maximum number of successes in stage 2 not to warrant further investigation (6) n: the total number of subjects (stage 1 + stage 2) (7) ESS: the expected sample size for each arm (8) PS:the probability of early stopping
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Zongheng Cai, Haitao Pan
</p>


<h3>References</h3>

<p>Cai, Z., Pan, H., Wu, J., Hsu, C.W. (2024). Uncontrolled Randomized Screening Selection Design for Pediatric Oncology Trials. Accepted in Book Chapter of &quot;Master Protocol Clinical Trial for Efficient Evidence Generation&quot;
</p>
<p>Wu, J., Pan, H., &amp; Hsu, C. W. (2022). Two-stage screened selection designs for randomized phase II trials
with time-to-event endpoints. Biometrical Journal, 64(7), 1207-1218
</p>
<p>Yap, C., Pettitt, A. &amp; Billingham, L. Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol 13, 87 (2013)
</p>


<h3>Examples</h3>

<pre><code class='language-R'>optimal_3arm_binary(p0 = 0.2, p1 = 0.415, p2 = 0.515, p3 = 0.615,
                    alpha = 0.1, beta = 0.2, tot_sample = 82)
</code></pre>

<hr>
<h2 id='sample_size_2arm_binary'>
Calculate the sample size for each arm in a two-arm trial
</h2><span id='topic+sample_size_2arm_binary'></span>

<h3>Description</h3>

<p>Calculate the sample size for each arm in a two-arm trial
</p>


<h3>Usage</h3>

<pre><code class='language-R'>sample_size_2arm_binary(p0, p1, p2, diff = 0, selection.prob = 0.9,
                        alpha = 0.1, beta = 0.2)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="sample_size_2arm_binary_+3A_p0">p0</code></td>
<td>

<p>the successful probability of historical data
</p>
</td></tr>
<tr><td><code id="sample_size_2arm_binary_+3A_p1">p1</code></td>
<td>

<p>the response rate of arm 1
</p>
</td></tr>
<tr><td><code id="sample_size_2arm_binary_+3A_p2">p2</code></td>
<td>

<p>the response rate of arm 2
</p>
</td></tr>
<tr><td><code id="sample_size_2arm_binary_+3A_diff">diff</code></td>
<td>

<p>the equivalence margin
</p>
</td></tr>
<tr><td><code id="sample_size_2arm_binary_+3A_selection.prob">selection.prob</code></td>
<td>

<p>the probability of selection of a superior arm. The default value is selection.prob = 0.9
</p>
</td></tr>
<tr><td><code id="sample_size_2arm_binary_+3A_alpha">alpha</code></td>
<td>

<p>the type I error to be controlled. The default value is alpha = 0.1
</p>
</td></tr>
<tr><td><code id="sample_size_2arm_binary_+3A_beta">beta</code></td>
<td>

<p>the type II error to be controlled. The default value is beta = 0.2
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>sample_size_2arm_binary()</code> returns required sample size for each arm
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Zongheng Cai, Haitao Pan
</p>


<h3>References</h3>

<p>Cai, Z., Pan, H., Wu, J., Hsu, C.W. (2024). Uncontrolled Randomized Screening Selection Design for Pediatric Oncology Trials. Accepted in Book Chapter of &quot;Master Protocol Clinical Trial for Efficient Evidence Generation&quot;
</p>
<p>Wu, J., Pan, H., &amp; Hsu, C. W. (2022). Two-stage screened selection designs for randomized phase II trials
with time-to-event endpoints. Biometrical Journal, 64(7), 1207-1218
</p>
<p>Yap, C., Pettitt, A. &amp; Billingham, L. Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol 13, 87 (2013)
</p>


<h3>Examples</h3>

<pre><code class='language-R'>sample_size_2arm_binary(p0 = 0.2, p1 = 0.415, p2 = 0.615)
</code></pre>

<hr>
<h2 id='sample_size_3arm_binary'>
Calculate the sample size for each arm in a three-arm study
</h2><span id='topic+sample_size_3arm_binary'></span>

<h3>Description</h3>

<p>Calculate the sample size for each arm in a three-arm trial
</p>


<h3>Usage</h3>

<pre><code class='language-R'>sample_size_3arm_binary(p0, p1, p2, p3, diff = 0, selection.prob = 0.9, alpha = 0.1,
                 beta = 0.2)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="sample_size_3arm_binary_+3A_p0">p0</code></td>
<td>

<p>the response rate of historical control arm
</p>
</td></tr>
<tr><td><code id="sample_size_3arm_binary_+3A_p1">p1</code></td>
<td>

<p>the response rate of arm 1
</p>
</td></tr>
<tr><td><code id="sample_size_3arm_binary_+3A_p2">p2</code></td>
<td>

<p>the response rate of arm 2
</p>
</td></tr>
<tr><td><code id="sample_size_3arm_binary_+3A_p3">p3</code></td>
<td>

<p>the response rate of arm 3
</p>
</td></tr>
<tr><td><code id="sample_size_3arm_binary_+3A_diff">diff</code></td>
<td>

<p>the equivalence margin. The default value is diff = 0
</p>
</td></tr>
<tr><td><code id="sample_size_3arm_binary_+3A_selection.prob">selection.prob</code></td>
<td>

<p>the probability of selection of a superior arm. The default value is selection.prob = 0.9
</p>
</td></tr>
<tr><td><code id="sample_size_3arm_binary_+3A_alpha">alpha</code></td>
<td>

<p>the type I error to be controlled. The default value is alpha = 0.1
</p>
</td></tr>
<tr><td><code id="sample_size_3arm_binary_+3A_beta">beta</code></td>
<td>

<p>the type II error to be controlled. The default value is beta = 0.2
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>sample_size_3arm_binary()</code> returns required sample size for each arm
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Zongheng Cai, Haitao Pan
</p>


<h3>References</h3>

<p>Cai, Z., Pan, H., Wu, J., Hsu, C.W. (2024). Uncontrolled Randomized Screening Selection Design for Pediatric Oncology Trials. Accepted in Book Chapter of &quot;Master Protocol Clinical Trial for Efficient Evidence Generation&quot;
</p>
<p>Wu, J., Pan, H., &amp; Hsu, C. W. (2022). Two-stage screened selection designs for randomized phase II trials
with time-to-event endpoints. Biometrical Journal, 64(7), 1207-1218
</p>
<p>Yap, C., Pettitt, A. &amp; Billingham, L. Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol 13, 87 (2013)
</p>


<h3>Examples</h3>

<pre><code class='language-R'>sample_size_3arm_binary(p0 = 0.2, p1 = 0.415, p2 = 0.515, p3 = 0.615)
</code></pre>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
